A 16-mer peptide (RQIKIWFQNRRMKWKK) from antennapedia preferentially targets the Class I pathway

被引:44
作者
Pietersz, GA
Li, WJ
Apostolopoulos, V
机构
[1] Austin Res Inst, Heidelberg, Vic 3084, Australia
[2] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA
关键词
peptide; cytotoxic T lymphocyte; disease;
D O I
10.1016/S0264-410X(00)00373-X
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Translocation of antigenic peptides into the cytosol of antigen presenting cells facilitates proteosomal processing and loading into Class I molecules for MHC presentation on the cell surface. The DNA binding domain of the Drosophila transcription factor (Antennapedia), a 60 amino acid protein, is rapidly taken up by cells and has been fused to selected antigens to enhance their immunogenicity. We now demonstrate that a 16 amino acid peptide from antennapedia can facilitate the cytoplasmic uptake of CTL epitope 9-mer peptides. Synthetic peptides were made containing the 16-mer antennapedia peptide linked in tandem to the ovalbumin SIINFEKL CTL peptide. The peptide complex was shown to rapidly internalise into APCs by confocal microscopy. This peptide induced CTL in C57BL/6 mice and protected them against growth of an ovalbumin expressing tumour cell line (E.G7-OVA). The ability of the hybrid peptide to be processed and presented by APCs was similar, whether the SIINFEKL sequence was appended at the C-terminus or N-terminus of the Antennapedia peptide. The production of synthetic peptides containing other CTL peptide epitopes map be useful for priming CTLs in vitro and in vivo (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1397 / 1405
页数:9
相关论文
共 30 条
[11]  
Jaeger E, 1996, INT J CANCER, V66, P162
[12]   CTL-defined cancer vaccines:: Perspectives for active immunotherapeutic interventions in minimal residual disease [J].
Jäger, E ;
Jäger, D ;
Knuth, A .
CANCER AND METASTASIS REVIEWS, 1999, 18 (01) :143-150
[13]   DETECTION OF RARE ANTIGEN-PRESENTING CELLS BY THE LACZ T-CELL ACTIVATION ASSAY SUGGESTS AN EXPRESSION CLONING STRATEGY FOR T-CELL ANTIGENS [J].
KARTTUNEN, J ;
SANDERSON, S ;
SHASTRI, N .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (13) :6020-6024
[14]  
Kim DT, 1997, J IMMUNOL, V159, P1666
[15]  
Lee RS, 1998, EUR J IMMUNOL, V28, P2726, DOI 10.1002/(SICI)1521-4141(199809)28:09<2726::AID-IMMU2726>3.3.CO
[16]  
2-N
[17]  
LIPFORD GB, 1993, J IMMUNOL, V150, P1212
[18]  
MCKENZIE IFC, 1990, CANC CELLS, V2, P191
[19]   INTRODUCTION OF SOLUBLE-PROTEIN INTO THE CLASS-I PATHWAY OF ANTIGEN PROCESSING AND PRESENTATION [J].
MOORE, MW ;
CARBONE, FR ;
BEVAN, MJ .
CELL, 1988, 54 (06) :777-785
[20]   INTRODUCTION OF MACROMOLECULES INTO CULTURED MAMMALIAN-CELLS BY OSMOTIC LYSIS OF PINOCYTIC VESICLES [J].
OKADA, CY ;
RECHSTEINER, M .
CELL, 1982, 29 (01) :33-41